BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 22126861)

  • 1. Clinical significance of fibroblast-specific protein-1 expression on podocytes in patients with focal segmental glomerulosclerosis.
    Samejima K; Nakatani K; Suzuki D; Asai O; Sakan H; Yoshimoto S; Yamaguchi Y; Matsui M; Akai Y; Toyoda M; Iwano M; Saito Y
    Nephron Clin Pract; 2012; 120(1):c1-7. PubMed ID: 22126861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultrastructural features and expression of cytoskeleton proteins of podocyte from patients with minimal change disease and focal segmental glomerulosclerosis.
    Shi SF; Wang SX; Zhang YK; Zhao MH; Zou WZ
    Ren Fail; 2008; 30(5):477-83. PubMed ID: 18569926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of DENDRIN in several glomerular diseases and correlation to pathological parameters and renal failure - preliminary study.
    Mizdrak M; Vukojević K; Filipović N; Čapkun V; Benzon B; Durdov MG
    Diagn Pathol; 2018 Nov; 13(1):90. PubMed ID: 30458823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In situ evaluation of podocytes in patients with focal segmental glomerulosclerosis and minimal change disease.
    da Silva CA; Monteiro MLGDR; Araújo LS; Urzedo MG; Rocha LB; Dos Reis MA; Machado JR
    PLoS One; 2020; 15(11):e0241745. PubMed ID: 33147279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dystroglycan in the diagnosis of FSGS.
    Giannico G; Yang H; Neilson EG; Fogo AB
    Clin J Am Soc Nephrol; 2009 Nov; 4(11):1747-53. PubMed ID: 19808230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of fibroblast specific protein 1 expression in the progression of adriamycin-induced glomerulosclerosis.
    Nakatani K; Asai O; Konishi N; Iwano M
    Biochem Biophys Res Commun; 2021 Aug; 567():148-153. PubMed ID: 34153685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Podocin and uPAR are good biomarkers in cases of Focal and segmental glomerulosclerosis in pediatric renal biopsies.
    Pereira LHM; da Silva CA; Monteiro MLGDR; Araújo LS; Rocha LP; Reis MBDR; Ramalho FS; Corrêa RRM; Silva MV; Reis MA; Machado JR
    PLoS One; 2019; 14(6):e0217569. PubMed ID: 31188898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of urinary angiotensinogen as a marker of podocyte injury in proteinuric nephropathies.
    Eriguchi M; Yotsueda R; Torisu K; Kawai Y; Hasegawa S; Tanaka S; Noguchi H; Masutani K; Kitazono T; Tsuruya K
    Am J Physiol Renal Physiol; 2016 Feb; 310(4):F322-33. PubMed ID: 26632605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell-cycle regulatory proteins in the podocyte in collapsing glomerulopathy in children.
    Srivastava T; Garola RE; Singh HK
    Kidney Int; 2006 Aug; 70(3):529-35. PubMed ID: 16775597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Glomerular Transcriptome Profiles of Adult-Onset Steroid Sensitive Focal Segmental Glomerulosclerosis and Minimal Change Disease.
    Tong J; Xie J; Ren H; Liu J; Zhang W; Wei C; Xu J; Zhang W; Li X; Wang W; Lv D; He JC; Chen N
    PLoS One; 2015; 10(11):e0140453. PubMed ID: 26536600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vangl2, a planar cell polarity molecule, is implicated in irreversible and reversible kidney glomerular injury.
    Papakrivopoulou E; Vasilopoulou E; Lindenmeyer MT; Pacheco S; Brzóska HŁ; Price KL; Kolatsi-Joannou M; White KE; Henderson DJ; Dean CH; Cohen CD; Salama AD; Woolf AS; Long DA
    J Pathol; 2018 Dec; 246(4):485-496. PubMed ID: 30125361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AMPK mediates regulation of glomerular volume and podocyte survival.
    Banu K; Lin Q; Basgen JM; Planoutene M; Wei C; Reghuvaran AC; Tian X; Shi H; Garzon F; Garzia A; Chun N; Cumpelik A; Santeusanio AD; Zhang W; Das B; Salem F; Li L; Ishibe S; Cantley LG; Kaufman L; Lemley KV; Ni Z; He JC; Murphy B; Menon MC
    JCI Insight; 2021 Oct; 6(19):. PubMed ID: 34473647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of C4d expression and staining patterns by immunohistochemistry in renal biopsy samples with focal segmental glomerulosclerosis and minimal change disease.
    Abedi M; Nili F; Dehkhoda F; Abdollahi A; Salarvand S
    Ann Diagn Pathol; 2024 Jun; 70():152281. PubMed ID: 38417352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epithelial-mesenchymal transition as a potential explanation for podocyte depletion in diabetic nephropathy.
    Yamaguchi Y; Iwano M; Suzuki D; Nakatani K; Kimura K; Harada K; Kubo A; Akai Y; Toyoda M; Kanauchi M; Neilson EG; Saito Y
    Am J Kidney Dis; 2009 Oct; 54(4):653-64. PubMed ID: 19615802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Any value of podocyte B7-1 as a biomarker in human MCD and FSGS?
    Novelli R; Gagliardini E; Ruggiero B; Benigni A; Remuzzi G
    Am J Physiol Renal Physiol; 2016 Mar; 310(5):F335-41. PubMed ID: 26697986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoexpression of podocyte-associated proteins in acquired human glomerulopathies with nephrotic syndrome.
    Wagrowska-Danilewicz M; Stasikowska O; Danilewicz M
    Pol J Pathol; 2006; 57(1):17-21. PubMed ID: 16739878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Focal and segmental glomerulosclerosis in murine models: a histological and ultrastructural characterization with immunohistochemistry correlation of glomerular CD44 and WT1 expression.
    Husain S; Ginawi I; Bashir AI; Kfoury H; Al Johani TE; Hagar H; Raddaoui L; Al Ghonaim M; Alsuwaida A
    Ultrastruct Pathol; 2018; 42(5):430-439. PubMed ID: 30285525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Morphologic Analysis of Urinary Podocytes in Focal Segmental Glomerulosclerosis.
    Shirai Y; Miura K; Yokoyama T; Horita S; Nakayama H; Seino H; Ando T; Shiratori A; Yabuuchi T; Kaneko N; Ishiwa S; Ishizuka K; Hara M; Hattori M
    Kidney360; 2021 Mar; 2(3):477-486. PubMed ID: 35369007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Connective tissue growth factor modulates podocyte actin cytoskeleton and extracellular matrix synthesis and is induced in podocytes upon injury.
    Fuchshofer R; Ullmann S; Zeilbeck LF; Baumann M; Junglas B; Tamm ER
    Histochem Cell Biol; 2011 Sep; 136(3):301-19. PubMed ID: 21814837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Podocyte expression of nonmuscle myosin heavy chain-IIA decreases in idiopathic nephrotic syndrome, especially in focal segmental glomerulosclerosis.
    Miura K; Kurihara H; Horita S; Chikamoto H; Hattori M; Harita Y; Tsurumi H; Kajiho Y; Sawada Y; Sasaki S; Igarashi T; Kunishima S; Sekine T
    Nephrol Dial Transplant; 2013 Dec; 28(12):2993-3003. PubMed ID: 24042022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.